Welcome Back |Sign in | Register
Your Position: Home > Inhibitors/Agonists > SU5402

View History

SU5402
prev zoom next

Name:SU5402

  • Catalog No.:
  • BCM006866
  • Chem Name:
  • 3-[4-methyl-2-[(Z)-(2-oxo-1H-indol-3-ylidene)methyl]-1H-pyrrol-3-yl]propanoic acid
  • Synonym:
  • SU5402; SU 5402; SU-5402
  • CAS No.:
  • 215543-92-3
  • MDL No.:
  • MFCD08235144
  • Formula:
  • C17H16N2O3
  • Molecular:
  • 296.32
  • Form:
  • Light orange to dark orange powder
  • Storage:
  • Keep in dark place. Sealed in dry, 2-8°C
  • Wish  | Compare  | Referral bonuses
SKU Specification Brand Prices Stock Quantity Cart
BCM006866-5MG 5mg, Purity:98% BCM $70 1 Add Cart
BCM006866-25MG 25mg, Purity:98% BCM $265 1 Add Cart
BCM006866-50MG 50mg, Purity:98% BCM $440 1 Add Cart
For more quantities, please contact telephone:0755-85269922,Or send an email to:sales@biochemmall.com

Product Description

Attribute

Goods Tag

Related Products

 

SU5402 is a potent multi-target receptor kinase inhibitor with an IC50 of 20 nM, 30 nM, and 510 nM for VEGFR2, FGFR1, and PDGF-Rβ, respectively.

 

Brand: BCM

 

Target: VEGFR; FGFR; PDGFR

 

Signaling Pathways: Angiogenesis; Tyrosine Kinase/Adaptors

 

Melting Point: >222°C (dec.)

 

Boiling Point: 592.6±50.0 °C(Predicted)

 

pKa: 4.60±0.10(Predicted)

 

Solubility: Soluble in DMSO. Insoluble in Water; insoluble in Ethanol.

 

Isomeric SMILES: CC1=CNC(=C1CCC(=O)O)/C=C\2/C3=CC=CC=C3NC2=O  

 

InChIKey: JNDVEAXZWJIOKB-JYRVWZFOSA-N  

 

InChI: InChI=1S/C17H16N2O3/c1-10-9-18-15(11(10)6-7-16(20)21)8-13-12-4-2-3-5-14(12)19-17(13)22/h2-5,8-9,18H,6-7H2,1H3,(H,19,22)(H,20,21)/b13-8-

 

Attribute
[Chem Name] 3-[4-methyl-2-[(Z)-(2-oxo-1H-indol-3-ylidene)methyl]-1H-pyrrol-3-yl]propanoic acid
[Synonym] SU5402; SU 5402; SU-5402
[CAS No.] 215543-92-3
[MDL No.] MFCD08235144
[Formula] C17H16N2O3
[Molecular] 296.32
[Form] Light orange to dark orange powder
[Storage] Keep in dark place. Sealed in dry, 2-8°C

Goods Tag

User Comment(Total0User Comment Num)

  • No comment
Total 0 records, divided into1 pages. First Prev Next Last
Username: Anonymous user
E-mail:
Rank:
Content:
Verification code: captcha